Entangled tertiary folds

ProteoKnot aims to design entangled tertiary folds in synthetic molecules for dynamic functionality, enabling complex macromolecules with protein-like properties and switchable catalytic capabilities.

Subsidie
€ 1.999.454
2023

Projectdetails

Introduction

The most sophisticated functions of proteins emerge at the level of their tertiary structure and involve large amplitude conformational changes. In contrast, the functions of synthetic molecules are currently limited by our inability to control their structure beyond the level of static secondary structures.

Project Objectives

ProteoKnot seeks to address this limitation by introducing entanglements as a tool to control tertiary folding while maintaining the flexibility required to allow them to change conformation.

Objective 1: Design Principles

The first objective of this project is to establish design principles to guide the construction of entangled tertiary folds. These principles will be tested with the assembly of:

  1. Multiply-stranded helices (WP1)
  2. Entangled macromolecules (WP2)
  3. Polymers (WP3)

Objective 2: Photoswitchable Handles

The second objective is to introduce photoswitchable handles in these structures to enable remote control over their conformational states (WP4).

Impact on Macromolecule Engineering

Operating the transition from the traditional design of static secondary folds to the design of dynamic tertiary folds will unlock the possibility to engineer increasingly complex macromolecules with protein-like functions. These exquisite architectures feature tandem helical motifs and cavities, providing an avenue toward highly elaborated receptors and catalysts.

Future Applications

To illustrate the great potential of entangled tertiary folds for future applications, our third objective will be to develop their use as multi-responsive switchable catalysts (WP5).

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.999.454
Totale projectbegroting€ 1.999.454

Tijdlijn

Startdatum1-6-2023
Einddatum31-5-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • JYVASKYLAN YLIOPISTOpenvoerder

Land(en)

Finland

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Glycan foldamers: designing oligosaccharides to build three-dimensional architectures

The project aims to develop synthetic carbohydrate foldamers that adopt defined structures and assemble into complex architectures, enhancing understanding and applications in chemistry and material science.

€ 1.499.956
ERC Consolid...

Bringing Nanospace to Life by Adapting Pore Environments to Chemical Complexity

LIVINGPORE aims to develop synthetic porous materials with programmable pore environments for enhanced structural and functional responses, mimicking biological systems for innovative applications.

€ 1.998.974
ERC Starting...

BiFoldome: Homo- and Hetero-typic Interactions in Assembled Foldomes

BiFOLDOME aims to understand co-assembly in amyloids through innovative NMR techniques, enhancing insights into self-assembly and potential applications in disease-related protein manipulation.

€ 1.496.823
ERC Synergy ...

Mechanisms of co-translational assembly of multi-protein complexes

This project aims to uncover the mechanisms of co-translational protein complex assembly using advanced techniques to enhance understanding of protein biogenesis and its implications for health and disease.

€ 9.458.525
ERC Starting...

Evolution of shape-defined macromolecules into functional systems

Develop abiotic enzymes by fine-tuning macromolecular shape and sequence to catalyze chemical transformations in non-physiological environments, rivaling natural enzyme functionality.

€ 1.499.750

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Computation driven development of novel vivo-like-DNA-nanotransducers for biomolecules structure identification

This project aims to develop DNA-nanotransducers for real-time detection and analysis of conformational changes in biomolecules, enhancing understanding of molecular dynamics and aiding drug discovery.

€ 3.000.418